Literature DB >> 24611805

Immunoregulatory networks in human Chagas disease.

W O Dutra1, C A S Menezes, L M D Magalhães, K J Gollob.   

Abstract

Chagas disease, caused by the infection with Trypanosoma cruzi, is endemic in all Latin America. Due to the increase in population migration, Chagas disease has spread worldwide and is now considered a health issue not only in endemic countries. While most chronically infected individuals remain asymptomatic, approximately 30% of the patients develop a potentially deadly cardiomyopathy. The exact mechanisms that underlie the establishment and maintenance of the cardiac pathology are not clear. However, there is consistent evidence that immunoregulatory cytokines are critical for orchestrating the immune response and thus influence disease development or control. While the asymptomatic (indeterminate) form represents a state of balance between the host and the parasite, the establishment of the cardiac form represents the loss of this balance. Analysis of data obtained from several studies has led to the hypothesis that the indeterminate form is associated with an anti-inflammatory cytokine profile, represented by high expression of IL-10, while cardiac form is associated with a high production of IFN-gamma and TNF-alpha in relation to IL-10, leading to an inflammatory profile. Here, we discuss the immunoregulatory events that might influence disease outcome, as well as the mechanisms that influence the establishment of these complex immunoregulatory networks.
© 2014 John Wiley & Sons Ltd.

Entities:  

Keywords:  Chagas disease; Trypanosoma cruzi; cytokines; immunoregulation; neuroendocrine; pathology

Mesh:

Substances:

Year:  2014        PMID: 24611805      PMCID: PMC4143493          DOI: 10.1111/pim.12107

Source DB:  PubMed          Journal:  Parasite Immunol        ISSN: 0141-9838            Impact factor:   2.280


  79 in total

1.  Neurochemical coding of the enteric nervous system in chagasic patients with megacolon.

Authors:  A B M da Silveira; D D'Avila Reis; E C de Oliveira; S G Neto; A O Luquetti; D Poole; R Correa-Oliveira; J B Furness
Journal:  Dig Dis Sci       Date:  2007-03-24       Impact factor: 3.199

Review 2.  An update on Chagas disease (human American trypanosomiasis).

Authors:  A Moncayo; M I Ortiz Yanine
Journal:  Ann Trop Med Parasitol       Date:  2006-12

Review 3.  Genetic epidemiology of parasitic protozoa and other infectious agents: the need for an integrated approach.

Authors:  M Tibayrenc
Journal:  Int J Parasitol       Date:  1998-01       Impact factor: 3.981

4.  Genetic Variability of Trypanosoma cruzi:Implications for the Pathogenesis of Chagas Disease.

Authors:  A M Macedo; S D Pena
Journal:  Parasitol Today       Date:  1998-03

Review 5.  Chemokines, inflammation and Trypanosoma cruzi infection.

Authors:  Mauro M Teixeira; Ricardo T Gazzinelli; João S Silva
Journal:  Trends Parasitol       Date:  2002-06

6.  Identification of six Trypanosoma cruzi lineages by sequence-characterised amplified region markers.

Authors:  S Brisse; J C Dujardin; M Tibayrenc
Journal:  Mol Biochem Parasitol       Date:  2000-11       Impact factor: 1.759

Review 7.  Etiological treatment in patients infected by Trypanosoma cruzi: experiences in Argentina.

Authors:  Sergio Sosa-Estani; Elsa Leonor Segura
Journal:  Curr Opin Infect Dis       Date:  2006-12       Impact factor: 4.915

8.  Frequency of interferon- gamma -producing T cells specific for Trypanosoma cruzi inversely correlates with disease severity in chronic human Chagas disease.

Authors:  Susana A Laucella; Miriam Postan; Diana Martin; Bolyn Hubby Fralish; Maria C Albareda; Maria G Alvarez; Bruno Lococo; Gustavo Barbieri; Rodolfo J Viotti; Rick L Tarleton
Journal:  J Infect Dis       Date:  2004-02-17       Impact factor: 5.226

9.  IL-17 produced during Trypanosoma cruzi infection plays a central role in regulating parasite-induced myocarditis.

Authors:  Paulo Marcos da Matta Guedes; Fredy R S Gutierrez; Flavia L Maia; Cristiane M Milanezi; Grace K Silva; Wander R Pavanelli; João S Silva
Journal:  PLoS Negl Trop Dis       Date:  2010-02-16

10.  Neuroendocrine interactions in the immune system.

Authors:  Dennis D Taub
Journal:  Cell Immunol       Date:  2008-07-10       Impact factor: 4.868

View more
  54 in total

1.  Serum IL-10 Levels and Its Relationship with Parasitemia in Chronic Chagas Disease Patients.

Authors:  Fernando Salvador; Adrián Sánchez-Montalvá; Mónica Martínez-Gallo; Elena Sulleiro; Clara Franco-Jarava; Augusto Sao Avilés; Pau Bosch-Nicolau; Zaira Moure; Aroa Silgado; Israel Molina
Journal:  Am J Trop Med Hyg       Date:  2020-01       Impact factor: 2.345

Review 2.  Immunity and immune modulation in Trypanosoma cruzi infection.

Authors:  Fabíola Cardillo; Rosa Teixeira de Pinho; Paulo Renato Zuquim Antas; José Mengel
Journal:  Pathog Dis       Date:  2015-10-04       Impact factor: 3.166

Review 3.  Understanding CD8+ T Cell Immunity to Trypanosoma cruzi and How to Improve It.

Authors:  Eva V Acosta Rodríguez; Cintia L Araujo Furlan; Facundo Fiocca Vernengo; Carolina L Montes; Adriana Gruppi
Journal:  Trends Parasitol       Date:  2019-10-10

4.  Differential cytokine profiling in Chagasic patients according to their arrhythmogenic-status.

Authors:  Héctor Rodríguez-Angulo; Juan Marques; Ivan Mendoza; Marco Villegas; Alfredo Mijares; Núria Gironès; Manuel Fresno
Journal:  BMC Infect Dis       Date:  2017-03-21       Impact factor: 3.090

5.  T-Cell Immunophenotyping and Cytokine Production Analysis in Patients with Chagas Disease 4 Years after Benznidazole Treatment.

Authors:  Mauricio Llaguno; Marcos Vinicius da Silva; Lara Rocha Batista; Djalma Alexandre Alves da Silva; Rodrigo Cunha de Sousa; Luiz Antonio Pertili Rodrigues de Resende; Valdo Jose Dias da Silva; Eliane Lages-Silva; Carlo José Freire Oliveira; Juliana Reis Machado; Denise Bertulucci Rocha Rodrigues; Dalmo Correia; Virmondes Rodrigues
Journal:  Infect Immun       Date:  2019-07-23       Impact factor: 3.441

6.  Specific activation of CD4- CD8- double-negative T cells by Trypanosoma cruzi-derived glycolipids induces a proinflammatory profile associated with cardiomyopathy in Chagas patients.

Authors:  L S A Passos; L M D Magalhães; R P Soares; A F Marques; M do C P Nunes; K J Gollob; W O Dutra
Journal:  Clin Exp Immunol       Date:  2017-07-03       Impact factor: 4.330

Review 7.  Oxidative stress implications for therapeutic vaccine development against Chagas disease.

Authors:  Subhadip Choudhuri; Lizette Rios; Juan Carlos Vázquez-Chagoyán; Nisha Jain Garg
Journal:  Expert Rev Vaccines       Date:  2021-08-30       Impact factor: 5.217

8.  Modulation of Regulatory T Cells Activity by Distinct CD80 and CD86 Interactions With CD28/CTLA-4 in Chagas Cardiomyopathy.

Authors:  Bruna F Pinto; Nayara I Medeiros; Andrea Teixeira-Carvalho; Jacqueline A Fiuza; Silvana M Eloi-Santos; Maria C P Nunes; Silvana A Silva; Tereza C M Fontes-Cal; Mayara Belchior-Bezerra; Walderez O Dutra; Rodrigo Correa-Oliveira; Juliana A S Gomes
Journal:  Front Cardiovasc Med       Date:  2022-05-19

9.  Co-infection with distinct Trypanosoma cruzi strains induces an activated immune response in human monocytes.

Authors:  Luísa M D Magalhães; Lívia S A Passos; Egler Chiari; Lúcia M C Galvão; Carolina C Koh; Marina L Rodrigues-Alves; Rodolfo C Giunchetti; Kenneth Gollob; Walderez O Dutra
Journal:  Parasite Immunol       Date:  2019-09-30       Impact factor: 2.280

10.  IgG Subclass Analysis in Patients with Chagas Disease 4 Years After Benznidazole Treatment.

Authors:  Maurício Llaguno; Marcos Vinícius da Silva; Fernanda Rodrigues Helmo; Lara Rocha Batista; Djalma Alexandre Alves da Silva; Rodrigo Cunha de Sousa; Luiz Antonio Pertili Rodrigues de Resende; Eliane Lages-Silva; Carlo José Freire Oliveira; Juliana Reis Machado; Denise Bertulucci Rocha Rodrigues; Dalmo Correia; Virmondes Rodrigues
Journal:  Acta Parasitol       Date:  2021-06-11       Impact factor: 1.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.